Glycan-interacting compounds and methods of use
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 28, 2023
Grant Date -
N/A
app pub date -
Jan 29, 2020
filing date -
Nov 12, 2014
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention provides glycan-interacting antibodies and methods for producing glycan-interacting antibodies useful in the treatment and prevention of human disease, including cancer. Such glycan-interacting antibodies include monoclonal antibodies, derivatives, and fragments thereof as well as compositions and kits comprising them. Further provided are methods of using glycan-interacting antibodies to target cells and treat disease.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully